Cargando…
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
DIBI, a purpose-designed hydroxypyridinone-containing iron-chelating antimicrobial polymer was studied for its anti-staphylococcal activities in vitro in comparison to deferiprone, the chemically related, small molecule hydroxypyridinone chelator. The sensitivities of 18 clinical isolates of Staphyl...
Autores principales: | Parquet, Maria del Carmen, Savage, Kimberley A., Allan, David S., Davidson, Ross J., Holbein, Bruce E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103240/ https://www.ncbi.nlm.nih.gov/pubmed/30154764 http://dx.doi.org/10.3389/fmicb.2018.01811 |
Ejemplares similares
-
Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus
por: Allan, David S., et al.
Publicado: (2022) -
Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury
por: Lehmann, Christian, et al.
Publicado: (2022) -
Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains
por: Nocera, Francesca Paola, et al.
Publicado: (2022) -
Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses
por: Ghassemi-Rad, Javad, et al.
Publicado: (2023) -
Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis
por: Lehmann, Christian, et al.
Publicado: (2021)